TheProfitWatch

PRME - Prime Medicine, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
3.69 0.0 (-0.14%) 0.0 (0.0%) 0.0 (0.0%) -0.02 (-0.54%) -0.05 (-1.36%) 0.08 (2.36%) -0.05 (-1.37%) -0.02 (-0.55%)

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.41
Diluted EPS:
-0.41
Basic P/E:
-8.9878
Diluted P/E:
-8.9878
RSI(14) 1m:
52.63
VWAP:
3.69
RVol:

Events

Period Kind Movement Occurred At

Related News